EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study

Hemal Gada, Ramzi F Khalil, Stanley J Chetcuti, G Michael Deeb, Kendra J Grubb, Adam B Greenbaum, David Lorenz, Robert D Jumper, Ibrahim Sultan, Dustin Kliner, Paul Mahoney, Deepak R Talreja und 13 weitere

JACC: Cardiovascular Interventions · 2025-08 · 18 (16) · 2004-2017

DOI: 10.1016/j.jcin.2025.06.021 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-08. Verfasst von Hemal Gada und 24 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh Medical Center Central Pennsylvania Hospitals, Harrisburg, Pennsylvania, USA. Electronic address: gadah@upmc.edu. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medtronic Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleAortic Valve InsufficiencyCardiac Pacing, ArtificialPacemaker, ArtificialProspective StudiesProsthesis DesignRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsTreatment Outcome

Stichwörter der Autor:innen

commissural alignmentcusp overlap techniquedeployment techniquepacemaker implantation

Autor:innen und Institutionen

  • University of Pittsburgh Medical Center Central Pennsylvania Hospitals, Harrisburg, Pennsylvania, USA. Electronic address: gadah@upmc.edu.
  • Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
  • University of Michigan-Health System University Hospital, Ann Arbor, Michigan, USA.
  • Emory University, Atlanta, Georgia, USA.
  • Saint Vincent's Medical Center, Bridgeport, Connecticut, USA.
  • University of Pittsburgh Medical Center Presbyterian, Pittsburgh, Pennsylvania, USA.

Förderung

  • Medtronic Inc

Zitieren

APA

Gada, H., Khalil, R. F., Chetcuti, S. J., Deeb, G. M., Grubb, K. J., Greenbaum, A. B., Lorenz, D., Jumper, R. D., Sultan, I., Kliner, D., Mahoney, P., Talreja, D. R., Ahmed, M. I., Rovin, J. D., Lin, L., Sorajja, P., Fraser, D. G. W., Mittal, S., Nazif, T., …, & Yakubov, S. J. (2025). 30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study. JACC: Cardiovascular Interventions, 18(16), 2004-2017. https://doi.org/10.1016/j.jcin.2025.06.021

Vancouver

Gada H, Khalil RF, Chetcuti SJ, Deeb GM, Grubb KJ, Greenbaum AB, et al. 30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study. JACC: Cardiovascular Interventions. 2025;18(16):2004-2017. doi:10.1016/j.jcin.2025.06.021

BibTeX
@article{Gada2025,
  author = {Gada, Hemal and Khalil, Ramzi F and Chetcuti, Stanley J and Deeb, G Michael and Grubb, Kendra J and Greenbaum, Adam B and Lorenz, David and Jumper, Robert D and Sultan, Ibrahim and Kliner, Dustin and Mahoney, Paul and Talreja, Deepak R and Ahmed, Mustafa I and Rovin, Joshua D and Lin, Lang and Sorajja, Paul and Fraser, Douglas G W and Mittal, Suneet and Nazif, Tamim and Rodes-Cabau, Josep and Vora, Amit N and Ertelt, Kathleen and Tenhoff, Amanda C and Yeh, Yu Jung and Yakubov, Steven J},
  title = {30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {16},
  pages = {2004--2017},
  doi = {10.1016/j.jcin.2025.06.021}
}
Kostenlos starten →